| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000032068 |
| Receipt No. | R000036475 |
| Official scientific title of the study | Assessment of Restenotic Neointimal Tissue after Second- or Third-Generation Drug-Eluting Stent Implantation: Evaluation by Histopathology, Optimal Coherence Tomography, and Intravascular Ultrasound |
| Date of disclosure of the study information | 2018/04/04 |
| Last modified on | 2018/04/02 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Assessment of Restenotic Neointimal Tissue after Second- or Third-Generation Drug-Eluting Stent Implantation: Evaluation by Histopathology, Optimal Coherence Tomography, and Intravascular Ultrasound | |
| Title of the study (Brief title) | Assessment of Restenotic Neointimal Tissue after Second- or Third-Generation Drug-Eluting Stent Implantation: Evaluation by Histopathology, Optimal Coherence Tomography, and Intravascular Ultrasound | |
| Region |
|
|
| Condition | ||
| Condition | Coronary Artery Disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To assess restenotic neointimal tissue after second- or third-generation drug-eluting stent implantation by using optical coherence tomography (OCT), intravascular ultrasound (IVUS), and histopathology analysis of tissue obtained by directional coronary atherectomy (DCA) |
| Basic objectives2 | Others |
| Basic objectives -Others | Evaluation of pathological mechanism |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Histopathological findings, optical coherence tomography (OCT) findings, and intravascular ultrasound(IVUS) findings of restenotic neointimal tissue |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | -Patients who had restenosis after second- or third-generation DES implantation
-Restenotic lesion considered appropriate to be treated by DCA -Patients considered appropriate to be used OCT for assessment of restenotic neointimal lesion from the patients background -Patients who have provided written informed consent |
|||
| Key exclusion criteria | Those who were eligible to above criteria can be registered.
|
|||
| Target sample size | 15 | |||
| Research contact person | |
| Name of lead principal investigator | Yuji Oikawa |
| Organization | The Cardiovascular Institute |
| Division name | Cardiology |
| Address | 3-2-19, Nishiazabu Minato-ku, Tokyo, 106-0031, Japan |
| TEL | 03-3408-2151 |
| y-oikawa@cvi.or.jp | |
| Public contact | |
| Name of contact person | Riku Arai |
| Organization | The Cardiovascular Institute |
| Division name | Cardiology |
| Address | 3-2-19, Nishiazabu Minato-ku, Tokyo, 106-0031, Japan |
| TEL | 03-3408-2151 |
| Homepage URL | |
| r-arai@cvi.or.jp | |
| Sponsor | |
| Institute | The Cardiovascular Institute |
| Institute | |
| Department | |
| Funding Source | |
| Organization | The Cardiovascular Institute |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 心臓血管研究所付属病院(東京都) The Cardiovascular Institute
東海大学医学部内科学系循環器内科(神奈川県) Department of cardiology, Tokai university hospital |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Patients are recruiting
|
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036475 |